(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 3.87% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.5%.
Icon's revenue in 2026 is $8,102,602,000.On average, 21 Wall Street analysts forecast ICLR's revenue for 2026 to be $623,173,405,052, with the lowest ICLR revenue forecast at $570,637,771,836, and the highest ICLR revenue forecast at $659,673,452,548. On average, 19 Wall Street analysts forecast ICLR's revenue for 2027 to be $648,830,342,204, with the lowest ICLR revenue forecast at $586,673,357,556, and the highest ICLR revenue forecast at $688,461,146,912.
In 2028, ICLR is forecast to generate $702,511,374,400 in revenue, with the lowest revenue forecast at $619,889,927,976 and the highest revenue forecast at $781,162,104,360.